- Products & Solutions
- Access choices
- Application performance management
- Internet services
- IP address management
- Managed network services
- Virtual Private Network Services
- Network services solutions
- Business technology services
- CRM professional services
- IT professional services
- Mobility professional services
- Network professional services
- Unified communications professional services
- Field force automation
- Flexible working services
- Managed mobility services
- Secure remote access
- Telecom expense management
- Mobility solutions
- Why BT
Our position and recognition in published analyst reports.
We believe in the power of communication to make a better world
We are proud that our work is recognized time and again by customers, analysts and professional organizations
Our company overview: how we're bringing it all together around the world
Who we’ve helped, and how. Learn how organizations just like yours get better when they work with us.
Join us to explore fresh ideas
Explore and debate the big issues with us as we bring together the latest insight on the hottest IT trends.
From press releases to local news
Great thinking from across the company
Our range of showcases offers you an online or face-to-face insight into our portfolio and its capabilities.
- Let's Talk
- My Account
Press release: BT and Ulteo to help global life sciences teams create secure collaborative environments
DC14-188 (29 April 2014)
Cloud-based offering to empower users to access massive data sets in seconds, provides air-lock systems to protect and manage sensitive patient data
BT and Ulteo today announced that the two companies are now working closely together to help life sciences organizations use technology to create collaborative and secure analytical environments, leveraging BT for Life Sciences Cloud Compute solutions combined with Ulteo Open Virtual Desktop (OVD).
By combining BT’s Cloud Compute platform with the Ulteo OVD, life sciences companies can access a common platform that allows team members to remotely access large-scale projects – including data sets that extend to several petabytes – in a matter of seconds. In a traditional setting, a project of similar scale may take hours to load, and in many cases, requires significant logistical support to ship large hard drives to offices around the world.
The platform can be accessed directly from a user’s desktop, and provides an experience that looks and feels like a local application on the user’s computer. Three desktop environments will be supported and available to be delivered: Linux Gnome, Windows PC and a portal interface that will allow users to select from a list of applications in their web browser and open an application the same way they would on their desktop.
To manage sensitive patient data, the platform is also secured using federated identity management and controls that allow customers to control access to data by file type and clinical data record content. Additionally, the platform offers controls that allow users to view and work with data, but ensures that all information is ‘air locked’ within the system so that sensitive patient data can be accessed only as encrypted display information. Actual patient data never leaves the data center, ensuring that it cannot be removed or stolen.
The mutual goal for BT and Ulteo is to allow life sciences customers to focus on developing transformational medicine, without the worries and hassles of how to access large data sets and manage complex information sharing.
“What we’ve been able to create with BT is more than simply a remote desktop. It’s a powerful platform that allows users to quickly access and share massive amounts of data while maintaining a firewalled, secure environment,” said David Austin, VP Business Development at Ulteo.
Yury Rozenman, Business Development Director, BT for Life Sciences said, “We know that the users of these platforms are scientists first and foremost. By making it easier for them to quickly access and share information, we are helping to create an environment where they can focus on improving their drug development pipeline, while honoring medical privacy, and ultimately creating therapies that positively impact patients’ lives.”
BT is one of the world’s leading providers of communications services and solutions, serving customers in more than 170 countries. Its principal activities include the provision of networked IT services globally; local, national and international telecommunications services to its customers for use at home, at work and on the move; broadband, TV and internet products and services; and converged fixed/mobile products and services.BT consists principally of five lines of business: BT Global Services, BT Business, BT Consumer, BT Wholesale and Openreach.
For the year ended 31 March 2013, BT Group’s reported revenue was £18,103m with reported profit before taxation of £2,315m.
British Telecommunications plc (BT) is a wholly-owned subsidiary of BT Group plc and encompasses virtually all businesses and assets of the BT Group.BT Group plc is listed on stock exchanges in London and New York.
For more information, visit http://www.btplc.com/.
At Ulteo our vision is to enable organizations to connect their employees with the applications and information they need to be successful. By transforming the way applications and desktops are delivered we help streamline IT while enabling new ways of working.
Ulteo Open Virtual Desktop (OVD), the most cost efficient platform available in the market, is an easy to implement yet powerful solution that delivers virtualized desktops and applications from the cloud to PCs, laptops, Macs, tablets, smart phones, and thin clients.
Ulteo SAS is a commercial open source vendor, our customers benefit from the ethos of the open source model with the security and backing of a commercial enterprise. Our mission is to deliver non-proprietary platforms built on innovation, independence and an open architecture.
For more information visit http://www.ulteo.com.
For further information:
Please contact Alan Ball, Head of Global PR.